4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-21-068134
Chief Commercial Officer bought 35,200 shares at $1.34 ($47,168)
From the SEC's structured data for this filing
Trades in this filing
Evanson Jeff · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-03 | Purchase : show line 1 in the form | +35,200 | $1.34 | $47,168 | 1,177,130 | D |
| Open-market purchases · 35,200 sh · avg $1.34 · $47,168 | ||||||
Loading xslF345X03/doc4.xml…